In the remission stage of MS patients, iNKT cells produced more IL-4 and showed Th2-type response polarization, suggesting that iNKT cells may play an immunomodulatory role through Th2 type response in MS patients (Araki et al., 2003). Here, IL4 is linked to myeloid sarcoma.